drugset / Trial / NCT01007591

A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

NCT01007591

Phase 3 Completed 40 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

An international, multi-centre, prospective, randomised, double-blind, active-controlled, 2-arm, parallel group, 8-week, phase 3 clinical study in paediatric patients (aged 6 to 17 years) with psoriasis vulgaris on the face and on the intertriginous areas

Timeline

Start
2009-10
Primary completion
2010-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified Topical
Comparator LEO 80190 Unknown Topical

Indications